• Iktos and SRI to use AI for Covid-19 drug development pharmaceutical-technology
    March 05, 2020
    Artificial intelligence (AI) technology provider Iktos and research centre SRI International have partnered to discover and develop drugs to treat various viruses, including the novel coronavirus that causes Covid-19 and influenza.
  • Almirall signs deal for Iktos’ AI technology in drug design pharmaceutical-technology
    December 16, 2019
    Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs.
PharmaSources Customer Service